LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.31623
 40.14 84.90 18 3682 0.0049 -0.2481
MN20160318_Q02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 40.14 84.90 935 3682 0.2539 0.5545
MN20160318_Q02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 41.84 84.90 839 4003 0.2096 0.5099
MN20160318_Q02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 41.84 84.90 864 4003 0.2158 0.5179
MN20160318_Q02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 41.84 84.90 17 4003 0.0042 -0.2512
MN20160318_Q02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 41.84 84.90 822 4003 0.2053 0.5044
MN20160318_Q02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 43.55 84.90 759 4287 0.1770 0.4728
MN20160318_Q02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 43.55 84.90 776 4287 0.1810 0.4785
MN20160318_Q02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 43.55 84.90 18 4287 0.0042 -0.2398
MN20160318_Q02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 43.55 84.90 873 4287 0.2036 0.5096
MN20160318_Q02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 45.25 84.90 808 4539 0.1780 0.4806
MN20160318_Q02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 45.25 84.90 832 4539 0.1833 0.4882
MN20160318_Q02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 45.25 84.90 13 4539 0.0029 -0.2788
MN20160318_Q02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 45.25 84.90 897 4539 0.1976 0.5078
MN20160318_Q02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 46.95 84.90 774 4952 0.1563 0.4575
MN20160318_Q02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 46.95 84.90 791 4952 0.1597 0.4630
MN20160318_Q02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 46.95 84.90 19 4952 0.0038 -0.2252
MN20160318_Q02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 46.95 84.90 945 4952 0.1908 0.5080
MN20160318_Q02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 48.65 84.90 758 5328 0.1423 0.4428
MN20160318_Q02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 48.65 84.90 778 5328 0.1460 0.4491
MN20160318_Q02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 48.65 84.90 17 5328 0.0032 -0.2361
MN20160318_Q02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 48.65 84.90 994 5328 0.1865 0.5098
MN20160318_Q02
G16
MCF 10A-H2B-mCherry Neratinib
0.31623
 50.36 84.90 789 5651 0.1396 0.4450
MN20160318_Q02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 50.36 84.90 808 5651 0.1430 0.4506
MN20160318_Q02
E08
MCF 10A-H2B-mCherry Neratinib
0.31623
 50.36 84.90 22 5651 0.0039 -0.1999
MN20160318_Q02
G16